SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    T. Luger, N. Peukert, M. Rother, A multicentre, randomized, placebo-controlled trial establishing the treatment effect of TDT 068, a topical formulation containing drug-free ultra-deformable phospholipid vesicles, on the primary features of erythematotelangiectatic rosacea, Journal of the European Academy of Dermatology and Venereology, 2015, 29, 1
  2. 2
    Rajesh Krishna, Ying Guo, Valerie Schulz, Evyan Cord-Cruz, Shanna Smith, Suzanne Hair, Walter K. Nahm, Zoe D. Draelos, Non-obligatory role of prostaglandin D2 receptor subtype 1 in rosacea: Laropiprant in Comparison to a placebo did not alleviate the symptoms of erythematoelangiectaic rosacea, The Journal of Clinical Pharmacology, 2015, 55, 1
  3. 3
    J. Fowler, J. Tan, J.M. Jackson, K. Meadows, T. Jones, M. Jarratt, M. Leoni, Treatment of facial erythema in patients with rosacea with topical brimonidine tartrate: correlation of patient satisfaction with standard clinical endpoints of improvement of facial erythema, Journal of the European Academy of Dermatology and Venereology, 2015, 29, 1
  4. 4
    Clio Dessinioti, Christina Antoniou, Andreas Katsambas, Acneiform eruptions, Clinics in Dermatology, 2014, 32, 1, 24

    CrossRef

  5. 5
    Katharina Belge, Martin Schaller, Aktuelle, alternative und künftige Wege zur erfolgreichen Behandlung, hautnah dermatologie, 2014, 30, 5, 24

    CrossRef

  6. 6
    Lana X Tong, Angela Yen Moore, Brimonidine tartrate for the treatment of facial flushing and erythema in rosacea, Expert Review of Clinical Pharmacology, 2014, 7, 5, 567

    CrossRef

  7. 7
    K. Benkali, M. Leoni, F. Rony, R. Bouer, A. Fernando, M. Graeber, N. Wagner, Comparative pharmacokinetics and bioavailability of brimonidine following ocular and dermal administration of brimonidine tartrate ophthalmic solution and gel in patients with moderate-to-severe facial erythema associated with rosacea, British Journal of Dermatology, 2014, 171, 1
  8. 8
    F.G. Hougeir, Érythème de la rosacée : un traitement nouveau et efficace, Annales de Dermatologie et de Vénéréologie, 2014, 141, S169

    CrossRef

  9. 9
    L. Misery, Inervación cutánea, EMC - Dermatología, 2014, 48, 2, 1

    CrossRef

  10. 10
    James Q Del Rosso, Management of cutaneous rosacea: emphasis on new medical therapies, Expert Opinion on Pharmacotherapy, 2014, 15, 14, 2029

    CrossRef

  11. 11
    Scott A Davis, Steven R Feldman, Patterns of ambulatory care usage and leading treatments for rosacea, Journal of Dermatological Treatment, 2014, 25, 4, 275

    CrossRef

  12. 12
    Jerry Tan, Hong Liu, James J. Leyden, Matthew J. Leoni, Reliability of Clinician Erythema Assessment grading scale, Journal of the American Academy of Dermatology, 2014, 71, 4, 760

    CrossRef

  13. 13
    Yalçın Tüzün, Ronni Wolf, Zekayi Kutlubay, Özge Karakuş, Burhan Engin, Rosacea and rhinophyma, Clinics in Dermatology, 2014, 32, 1, 35

    CrossRef

  14. 14
    Farah A. Moustafa, Laura F. Sandoval, Steven R. Feldman, Rosacea: New and Emerging Treatments, Drugs, 2014, 74, 13, 1457

    CrossRef

  15. 15
    Montserrat Salleras i Redonnet, Nuria Lamas Doménech, Tratamiento del rubor facial (flushing), Piel, 2014, 29, 9, 587

    CrossRef

  16. 16
    David Piwnica, Carine Rosignoli, Séverine Thibaut de Ménonville, Thierry Alvarez, Marlene Schuppli Nollet, Olivier Roye, André Jomard, Jérôme Aubert, Vasoconstriction and anti-inflammatory properties of the selective α-adrenergic receptor agonist brimonidine, Journal of Dermatological Science, 2014, 75, 1, 49

    CrossRef

  17. 17
    James Q. Del Rosso, Management of facial erythema of rosacea: What is the role of topical α-adrenergic receptor agonist therapy?, Journal of the American Academy of Dermatology, 2013, 69, 6, S44

    CrossRef

  18. 18
    Martin Steinhoff, Jürgen Schauber, James J. Leyden, New insights into rosacea pathophysiology: A review of recent findings, Journal of the American Academy of Dermatology, 2013, 69, 6, S15

    CrossRef

  19. 19
    Markus Reinholz, Julia K. Tietze, Katharina Kilian, Martin Schaller, Helmut Schöfer, Percy Lehmann, Manfred Zierhut, Winfried Klövekorn, Thomas Ruzicka, Jürgen Schauber, Rosacea – S1 Guideline, JDDG: Journal der Deutschen Dermatologischen Gesellschaft, 2013, 11, 8
  20. 20
    Katharina Belge, Martin Schaller, Therapieoptionen im Blickpunkt, hautnah dermatologie, 2013, 29, 1, 27

    CrossRef

  21. 21
    H. Schöfer, Topische Therapie der Rosazea, Der Hautarzt, 2013, 64, 7, 494

    CrossRef

  22. 22
    Ulrich Mutschler, Wichtige Erkrankungen im Überblick, hautnah dermatologie, 2013, 29, 1, 20

    CrossRef

  23. 23
    Doris Day, Cosmeceuticals for Rosacea and Facial Redness,